Clinical Trials Logo

Reflux Disease clinical trials

View clinical trials related to Reflux Disease.

Filter by:
  • None
  • Page 1

NCT ID: NCT00757419 Completed - Reflux Disease Clinical Trials

AZD3355 Dose-escalation Study in Healthy Males

Start date: September 2008
Phase: Phase 1
Study type: Interventional

The aim is to establish the maximal tolerated dose of AZD3355 for the selection of doses in the up-coming studies. This will be done by comparing single and repeated doses of AZD3355 to placebo ("inactive substance"). Safety and tolerability variables will be closely monitored throughout the study.